[â—€è¿”å›](/è¯ç‰©/home.md)

# 1P-LSD

**1P-LSD**ï¼ˆ1-ä¸™é…°åŸº-d-éº¦è§’é…¸äºŒä¹™é…°èƒºï¼‰æ˜¯ä¸€ç§[éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨.md)çš„æ–°å‹[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)å“¦ã€‚å®ƒçš„ç»“æ„å’Œ[LSD](/è¯ç‰©/LSD.md)ä»¥åŠå…¶ä»–åƒ[1cP-LSD](/è¯ç‰©/1cP-LSD.md)ã€[1B-LSD](/è¯ç‰©/1B-LSD.md)è¿˜æœ‰[1V-LSD](/è¯ç‰©/1V-LSD.md)è¿™æ ·çš„æ–°å‹éº¦è§’é…¸é…°èƒºå¾ˆåƒå‘¢ã€‚è™½ç„¶å…·ä½“çš„åŸç†è¿˜æ²¡å®Œå…¨ææ¸…æ¥šï¼Œä½†å¤§å®¶è®¤ä¸ºå®ƒæ˜¯é€šè¿‡åˆºæ¿€å¤§è„‘é‡Œçš„[è¡€æ¸…ç´ ](/æ–‡æ¡£/è¡€æ¸…ç´ .md)å—ä½“æ¥äº§ç”Ÿæ•ˆæœçš„å˜›ã€‚

## æ¦‚è§ˆï¼š1P-LSD

| ç‰¹å¾ | å†…å®¹ |
| --- | --- |
| **åŒ–å­¦åç§°** | 1-Propionyl-d-lysergic acid diethylamide |
| **é€šç”¨åç§°** | 1P-LSD |
| **ç²¾ç¥è¯æ•ˆåˆ†ç±»** | [è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md) |
| **åŒ–å­¦åˆ†ç±»** | [éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨.md) |
| **ç»™è¯é€”å¾„** | [å£æœ](/æ–‡æ¡£/ç»™è¯é€”å¾„.md#å£æœ) |

#### ğŸ’Š å‰‚é‡æŒ‡å— (å£æœ)

> **âš ï¸ è­¦å‘Š**ï¼šç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»ä½å‰‚é‡å¼€å§‹å°è¯•å“¦ã€‚[å‚è§è´Ÿè´£ä»»çš„ç”¨è¯ç« èŠ‚](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

| å¼ºåº¦ | å‰‚é‡èŒƒå›´ |
| --- | --- |
| [é˜ˆå€¼](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#é˜ˆå€¼) | 15 Âµg |
| [è½»å¾®](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#è½»å¾®) | 25 - 75 Âµg |
| [ä¸­ç­‰](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸­ç­‰) | 75 - 150 Âµg |
| [å¼ºçƒˆ](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#å¼ºçƒˆ) | 150 - 300 Âµg |
| [ä¸¥é‡](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸¥é‡) | 300 Âµg + |

#### â±ï¸ è¯æ•ˆæ—¶é•¿

| é˜¶æ®µ | æ—¶é—´ |
| --- | --- |
| [æ€»æ—¶é•¿](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#æ€»æ—¶é•¿) | 8 - 12 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆå‘ä½œ) | 20 - 60 åˆ†é’Ÿ |
| [è¯æ•ˆä¸Šå‡](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆä¸Šå‡) | 45 - 120 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆè¾¾å³°) | 3 - 5 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆè¤ªå») | 3 - 5 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆæ®‹ä½™) | 6 - 24 å°æ—¶ |

---

è‡ª2015å¹´ä»¥æ¥ï¼Œ1P-LSDå°±ä½œä¸ºä¸€ç§[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ï¼ˆä¹Ÿè¢«ç§°ä¸ºâ€œç­–åˆ’è¯â€ï¼‰åœ¨ç½‘ä¸Šå‡ºå”®å•¦ï¼Œä½†å®ƒæœ€åˆæ˜¯ä»€ä¹ˆæ—¶å€™åˆæˆçš„æ²¡äººçŸ¥é“å‘¢ã€‚å’Œå¤§å¤šæ•°[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ä¸åŒï¼Œåœ¨2015å¹´å®ƒå‡ºç°åœ¨å¸‚åœºä¸Šä¹‹å‰ï¼Œæ–‡çŒ®é‡Œå¹¶æ²¡æœ‰å…³äºå®ƒçš„è®°å½•å“¦ã€‚

å®ƒå’Œ[ALD-52](/è¯ç‰©/ALD-52.md)ã€[ETH-LAD](/è¯ç‰©/ETH-LAD.md)ä»¥åŠ[AL-LAD](/è¯ç‰©/AL-LAD.md)ç­‰å…¶ä»–æ–°å‹[éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨.md)ä¸€èµ·ï¼Œè¢«å½“ä½œ[LSD](/è¯ç‰©/LSD.md)çš„åˆæ³•æ›¿ä»£å“æ¥å®£ä¼ ã€‚2019å¹´ï¼Œå®ƒæˆä¸ºäº†æ³•å›½Caulredaitenså®éªŒå®¤ç ”ç©¶çš„ä¸€ç»„åˆ†å­ä¹‹ä¸€å‘¢ã€‚

å®ƒçš„[ä¸»è§‚æ•ˆåº”](/è¯æ•ˆ/home.md)åŒ…æ‹¬[å‡ ä½•è§†è§‰å¹»è§‰](/è¯æ•ˆ/å‡ ä½•.md)ã€[æ—¶é—´æ‰­æ›²](/è¯æ•ˆ/æ—¶é—´æ‰­æ›².md)ã€[å†…çœå¢å¼º](/è¯æ•ˆ/å†…çœå¢å¼º.md)ã€[æ¦‚å¿µæ€§æ€ç»´](/è¯æ•ˆ/æ¦‚å¿µæ€§æ€ç»´.md)ã€[æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/æ¬£å¿«æ„Ÿ.md)å’Œ[è‡ªæˆ‘æ­»](/è¯æ•ˆ/è‡ªæˆ‘æ­».md)ã€‚ç”¨æˆ·çš„æŠ¥å‘Šè¡¨æ˜ï¼Œ1P-LSDçš„ä¸»è§‚æ•ˆåº”å’Œ[LSDçš„æ•ˆæœ](/è¯ç‰©/LSD.md#ä¸»è§‚æ•ˆåº”)æå…¶ç›¸ä¼¼ï¼Œç®€ç›´åˆ†ä¸å‡ºæ¥å‘¢ã€‚ç†è®ºä¸Šï¼Œå®ƒåœ¨ä½“å†…ä¼šä½œä¸ºLSDçš„[å‰è¯](/æ–‡æ¡£/è¯ç‰©å‰è¯.md)èµ·ä½œç”¨å“¦ã€‚

ä¸€é¡¹ç ”ç©¶ç»“æœæ”¯æŒäº†è¿™ä¸ªå‡è®¾ï¼Œè¯¥ç ”ç©¶è¡¨æ˜1P-LSDåœ¨å¤§é¼ ä½“å†…ä¼šä»£è°¢æˆLSDã€‚è¿™é¢„ç¤ºç€å®ƒä»¬çš„æ•ˆæœç‰¹å¾å‡ ä¹ä¸€æ ·ï¼Œå¯èƒ½ä¸»è¦åœ¨å¸æ”¶ç‡å’ŒæŒç»­æ—¶é—´ä¸Šæœ‰ç‚¹å°åŒºåˆ«ã€‚å› ä¸ºå®ƒç»å…¸çš„è¿·å¹»æ•ˆæœå’Œè‰¯å¥½çš„è€å—æ€§ï¼Œå®ƒåœ¨é‚£äº›å–œæ¬¢å°è¯•æ–°ç‰©è´¨çš„æœ‹å‹ä¸­å˜å¾—å¾ˆæµè¡Œï¼Œå¾ˆå¤šäººæŠŠå®ƒå½“ä½œLSDçš„æ›¿ä»£å“æ¥ç”¨å‘¢ã€‚

å…³äº1P-LSDçš„è¯ç†ç‰¹æ€§ã€ä»£è°¢å’Œæ¯’æ€§çš„æ•°æ®éå¸¸å°‘ã€‚è™½ç„¶æ²¡æœ‰æ­£å¼çš„ç ”ç©¶è¯æ˜ï¼Œä½†æ¨æµ‹å®ƒçš„æ¯’æ€§å’Œé£é™©çŠ¶å†µä¸[LSD](/è¯ç‰©/LSD.md)ç›¸ä¼¼ã€‚å¦‚æœè¦ä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œå¼ºçƒˆå»ºè®®é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)å“¦ï¼Œå®‰å…¨ç¬¬ä¸€å˜›ï¼

## ç›®å½•
1. [å†å²ä¸æ–‡åŒ–](#å†å²ä¸æ–‡åŒ–)
2. [åŒ–å­¦](#åŒ–å­¦)
3. [è¯ç†å­¦](#è¯ç†å­¦)
4. [ä¸»è§‚æ•ˆåº”](#ä¸»è§‚æ•ˆåº”)
5. [æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›](#æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›)
6. [æ³•å¾‹åœ°ä½](#æ³•å¾‹åœ°ä½)
7. [å¦è§](#å¦è§)
8. [å¤–éƒ¨é“¾æ¥](#å¤–éƒ¨é“¾æ¥)
9. [æ–‡çŒ®](#æ–‡çŒ®)
10. [å‚è€ƒèµ„æ–™](#å‚è€ƒèµ„æ–™)

## å†å²ä¸æ–‡åŒ–

1P-LSDæœ€æ—©åœ¨2015å¹´1æœˆå‡ºç°åœ¨åœ¨çº¿ç ”ç©¶ç”¨åŒ–å­¦å“å¸‚åœºä¸Šã€‚è™½ç„¶å®ƒå¯èƒ½æ˜¯åœ¨å­¦æœ¯ç¯å¢ƒä¸­è¢«å‘ç°çš„ï¼Œä½†æ²¡äººçŸ¥é“æ˜¯è°æœ€å…ˆåˆæˆäº†1P-LSDï¼Œå› ä¸ºåœ¨å®ƒè¿›å…¥å¸‚åœºä¹‹å‰ï¼Œä»»ä½•å­¦æœ¯æ–‡çŒ®ä¸­éƒ½æ²¡æœ‰å®ƒçš„èº«å½±å‘¢ã€‚

æœ‰è¶£çš„æ˜¯ï¼ŒDEAåœ¨1988å¹´çš„ä¸€ä»½æŠ¥å‘Šä¸­å°±é¢„è§åˆ°äº†è¿™ç§ç”¨æ³•â€”â€”å³ä½¿ç”¨1-çƒ·åŸºåŒ–éº¦è§’é…¸é…°èƒºè¡ç”Ÿç‰©æ¥ç»•è¿‡ç¦æ­¢[LSD](/è¯ç‰©/LSD.md)ä½œä¸ºå‰ä½“çš„å—æ§ç‰©è´¨æ³•å¾‹ï¼š

> â€œâ€¦â€¦å½“ç¾å›½åœ°ä¸‹åŒ–å­¦å®¶æ³¨æ„åˆ°éº¦è§’é…¸é…°èƒºè¢«åˆ—ä¸ºCFRé™„è¡¨IIIç‰©è´¨æ—¶ï¼Œè‡´å¹»æ´»æ€§çš„é™ä½å¯èƒ½ä¼šå˜å¾—å¯ä»¥æ¥å—ï¼›å› æ­¤ï¼Œè¿™ç§åŒ–åˆç‰©çš„ç»“æ„ç±»ä¼¼ç‰©ä¸å—CsAä¿®æ­£æ¡ˆçš„é™åˆ¶ã€‚äºæ˜¯å°±å¯ä»¥å¾—å‡ºä¸€ä¸ªæ¸…æ™°çš„è®ºç‚¹ï¼Œå³éº¦è§’é…¸N,N-äºŒç”²åŸºé…°èƒºæ˜¯è¡ç”Ÿè‡ªéº¦è§’é…¸é…°èƒºè€Œä¸æ˜¯LSDã€‚æŒ‰ç…§è¿™ä¸ªé€»è¾‘ç»§ç»­æ¨å¯¼ï¼Œäººä»¬å°±ä¼šå‡è®¾N,N-äºŒç”²åŸºå¼‚æ„ä½“çš„1-çƒ·åŸºå’Œ1-é…°åŸºè¡ç”Ÿç‰©ä¹Ÿä¸ä¼šå—åˆ°CsAä¿®æ­£æ¡ˆçš„ç®¡åˆ¶ã€‚â€
> â€” Donald A. Cooper, Future Synthetic Drugs of Abuse, 1988.

## åŒ–å­¦

1P-LSDæ˜¯[éº¦è§’é…¸é…°èƒº](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨.md)å®¶æ—çš„åŠåˆæˆåŒ–åˆç‰©ã€‚å®ƒå’Œ[LSD](/è¯ç‰©/LSD.md)å¾ˆåƒï¼Œåå­—æ¥æºäºLSDå¤šç¯å²å“šåŸºå›¢æ°®åŸå­ä¸Šç»“åˆçš„ä¸™é…°åŸºã€‚ä¸™é…°åŸºç”±ç»“åˆåœ¨æ°¨åŸºä¸Šçš„ç¾°åŸºé“¾CH3CH2CO-ç»„æˆå“¦ã€‚

1P-LSDæ˜¯[ALD-52](/è¯ç‰©/ALD-52.md)çš„åŒç³»ç‰©ï¼ŒALD-52åœ¨åŒä¸€ä½ç½®ç»“åˆçš„æ˜¯ä¹™é…°åŸºè€Œä¸æ˜¯ä¸™é…°åŸºã€‚1P-LSDçš„ç»“æ„åŒ…å«ä¸€ä¸ªåŒç¯å…­æ°¢å²å“šç»“åˆä¸€ä¸ªåŒç¯å–¹å•‰åŸºå›¢çš„å¤šç¯åŸºå›¢ã€‚åœ¨å–¹å•‰çš„ç¢³8ä½ç½®ï¼Œç»“åˆäº†ä¸€ä¸ªN,N-äºŒä¹™åŸºç”²é…°èƒºã€‚

## è¯ç†å­¦

å¦è§ï¼š[è¡€æ¸…ç´ èƒ½è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)

åŸºäºå®ƒå’ŒLSDçš„ç»“æ„ç›¸ä¼¼æ€§ï¼Œ1P-LSDå¾ˆå¯èƒ½ä½œä¸º[5-HT2A](/æ–‡æ¡£/è¡€æ¸…ç´ .md)å—ä½“çš„[éƒ¨åˆ†æ¿€åŠ¨å‰‚](/æ–‡æ¡£/å—ä½“æ¿€åŠ¨å‰‚.md)èµ·ä½œç”¨ã€‚å®ƒçš„[è¿·å¹»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)æ•ˆæœè¢«è®¤ä¸ºä¸»è¦æ¥è‡ªäºå®ƒå¯¹åˆ†å¸ƒåœ¨å¤§è„‘å„å¤„çš„5-HT2Aå—ä½“çš„ä½œç”¨å‘¢ã€‚

1P-LSDä¹Ÿå¾ˆå¯èƒ½å¯¹å„ç§[å•èƒº](/æ–‡æ¡£/ç¥ç»é€’è´¨.md)å—ä½“æ˜¾ç¤ºå‡ºç»“åˆæ´»æ€§ï¼Œæ¯”å¦‚[å¤šå·´èƒº](/æ–‡æ¡£/å¤šå·´èƒº.md)å’Œ[å»ç”²è‚¾ä¸Šè…ºç´ ](/æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md)å—ä½“ã€‚ä¸è¿‡ï¼Œç›®å‰è¿˜æ²¡æœ‰å®éªŒæ•°æ®æ”¯æŒè¿™äº›è¯´æ³•å“¦ã€‚

ç†è®ºä¸Šï¼Œ1P-LSDå¯èƒ½æ˜¯[LSD](/è¯ç‰©/LSD.md)çš„[å‰è¯](/æ–‡æ¡£/è¯ç‰©å‰è¯.md)ã€‚è™½ç„¶1P-LSDåœ¨å°é¼ ä½“å†…çš„æ•ˆåŠ›åªæœ‰LSDçš„38%ï¼Œä½†å½“1P-LSDåœ¨äººè¡€æ¸…ä¸­å­µè‚²æ—¶ï¼Œé€šè¿‡LC-MSå¯ä»¥æ£€æµ‹åˆ°LSDã€‚ç›®å‰æ­£åœ¨è¿›è¡Œåç»­ç ”ç©¶ï¼Œæ¯”è¾ƒLSDå’Œ1P-LSDåœ¨5-HTå—ä½“ä¸Šçš„äº²å’ŒåŠ›å’Œé€‰æ‹©æ€§ï¼Œå¹¶ç¡®å®š1P-LSDæ˜¯å¦åœ¨ä½“å†…æ°´è§£ä¸ºLSDã€‚é™¤æ­¤ä¹‹å¤–ï¼Œ1P-LSDä¹Ÿæœ‰å¯èƒ½æœ¬èº«å°±å…·æœ‰æ´»æ€§å‘¢ã€‚

åœ¨ä¸Šè¿°ç ”ç©¶å‘è¡¨ä¹‹å‰ï¼Œè¯ç‰©åŒ–å­¦å®¶å’Œè¿·å¹»å‰‚ç ”ç©¶å‘˜[David E. Nichols](https://en.wikipedia.org/wiki/David_E._Nichols)æ®æŠ¥é“åœ¨ç§äººé€šä¿¡ä¸­è¯„è®ºäº†1P-LSDæ½œåœ¨çš„è¡€æ¸…ç´ å—ä½“ç»“åˆåŠ¨åŠ›å­¦ï¼š

> â€œæˆ‘ç¡®ä¿¡1-ä¸™é…°åŸºä¹Ÿä¼šä»å²å“šä¸Šæ°´è§£ä¸‹æ¥ï¼Œä½†æˆ‘ä¸çŸ¥é“ä½“å†…æ¡ä»¶æ˜¯å¦å…è®¸ã€‚åœ¨åŒ–å­¦å®éªŒå®¤é‡Œï¼Œä½ å¯ä»¥å»æ‰N-è‹¯ç”²é…°åŸºï¼Œæ‰€ä»¥N-ä¸™é…°åŸºå¯èƒ½ä¹Ÿä¼šæ‰ä¸‹æ¥ã€‚ä½†åœ¨ä½“å†…å‘¢ï¼Ÿæˆ‘ä¸çŸ¥é“ç­”æ¡ˆã€‚ä¸è¿‡ï¼Œä½œä¸ºN-ä¸™é…°åŸºåŒ–åˆç‰©ï¼Œå®ƒæœ¬èº«æ˜¯æ²¡æœ‰æ´»æ€§çš„ã€‚LSDåœé åœ¨5-HT2Aå—ä½“çš„æ–¹å¼æ˜¯å²å“šNHä¸ä¸æ°¨é…¸5.46å½¢æˆæ°¢é”®ã€‚æœ‰äº†ä¸™é…°åŸºï¼Œå®ƒå°±å¡ä¸è¿›å—ä½“äº†ã€‚â€
> â€” David E. Nichols.

2020å¹´ä¸€é¡¹é’ˆå¯¹ä¸¤åäººç±»ç”·æ€§å¿—æ„¿è€…çš„ç ”ç©¶å‘ç°ï¼Œæœç”¨å1P-LSDåœ¨è¡€æ¸…ä¸­çš„æ°´å¹³åœ¨ç¬¬ä¸€å°æ—¶å†…è¿…é€Ÿä¸‹é™ï¼Œè€ŒLSDåœ¨å®éªŒè¿‡ç¨‹ä¸­ä¸€ç›´è¢«æ£€æµ‹åˆ°ï¼Œè¿™è¿›ä¸€æ­¥æ”¯æŒäº†å‰è¯ç†è®ºå“¦ã€‚ç ”ç©¶è¿˜å‘ç°ï¼Œå£æœ1P-LSDåï¼ŒLSDçš„ç”Ÿç‰©åˆ©ç”¨åº¦æ¥è¿‘100%å‘¢ã€‚

## ä¸»è§‚æ•ˆåº”

è®¸å¤šç”¨æˆ·çš„è½¶äº‹æŠ¥å‘Šè¡¨æ˜ï¼Œ1P-LSDçš„ä¸»è§‚æ•ˆåº”ä¸[LSD](/è¯ç‰©/LSD.md)æå…¶ç›¸ä¼¼ï¼Œå‡ ä¹æ— æ³•åŒºåˆ†ã€‚ä¸[èµ›æ´›è¥¿å®¾](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)ã€[LSA](/è¯ç‰©/LSA.md)å’Œ[æ­»è—¤æ°´](/è¯ç‰©/æ­»è—¤æ°´.md)ç­‰å…¶ä»–è¿·å¹»å‰‚ç›¸æ¯”ï¼Œ1P-LSDåœ¨å…¶èº«ä½“å’Œè®¤çŸ¥æ•ˆæœçš„å…·ä½“é£æ ¼ä¸Šæ˜æ˜¾æ›´åŠ åˆºæ¿€å’Œå¿«èŠ‚å¥ã€‚

> **å…è´£å£°æ˜**ï¼šä»¥ä¸‹çš„æ•ˆåº”åˆ—è¡¨å‚è€ƒäº†[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](/è¯æ•ˆ/home.md) (**SEI**)ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ[PsychonautWiki](https://psychonautwiki.org)è´¡çŒ®è€…ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”è¯¥å¸¦ç€å¥åº·çš„æ€€ç–‘æ€åº¦æ¥çœ‹å¾…å®ƒä»¬å“¦ã€‚
>
> *å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆæœä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡é«˜å‰‚é‡æ›´å®¹æ˜“è¯±å‘å…¨æ–¹ä½çš„æ•ˆæœã€‚åŒæ ·ï¼Œ**ä¸è‰¯ååº”**åœ¨é«˜å‰‚é‡ä¸‹å‘ç”Ÿçš„å¯èƒ½æ€§ä¹Ÿä¼šå¢åŠ ï¼Œå¯èƒ½åŒ…æ‹¬**æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡*** â˜ ã€‚

### **èº«ä½“æ•ˆåº”**

*   **[åˆºæ¿€](/è¯æ•ˆ/åˆºæ¿€.md)** - 1P-LSDé€šå¸¸è¢«è®¤ä¸ºæ˜¯éå¸¸å……æ»¡æ´»åŠ›å’Œåˆºæ¿€çš„ï¼Œä½†ä¸ä¼šè®©äººæ„Ÿåˆ°å‹‰å¼ºã€‚ä¾‹å¦‚ï¼Œåœ¨ä»»ä½•ç¯å¢ƒä¸‹æœç”¨ï¼Œé€šå¸¸éƒ½ä¼šé¼“åŠ±è·‘æ­¥ã€æ•£æ­¥ã€æ”€çˆ¬æˆ–è·³èˆç­‰èº«ä½“æ´»åŠ¨ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼Œåƒ[èµ›æ´›è¥¿å®¾](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)è¿™æ ·æ›´å¸¸ç”¨çš„è¿·å¹»å‰‚é€šå¸¸æ˜¯é•‡é™å’Œæ”¾æ¾çš„ã€‚
*   **[è‡ªå‘æ€§èº¯ä½“æ„Ÿè§‰](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)** - ä¸ä¼´éšçš„è§†è§‰å’Œè®¤çŸ¥æ•ˆæœç›¸æ¯”ï¼Œ1P-LSDçš„â€œèº«ä½“Highâ€å¯ä»¥è¯´éå¸¸å¼ºçƒˆã€‚å®ƒè¡¨ç°ä¸ºä¸€ç§æ¬£å¿«ã€å¿«é€Ÿç§»åŠ¨ã€é”åˆ©ä¸”ç‰¹å®šä½ç½®çš„åˆºç—›æ„Ÿã€‚å¯¹ä¸€äº›äººæ¥è¯´ï¼Œå®ƒåœ¨æ—…ç¨‹çš„ä¸åŒã€ä¸å¯é¢„æµ‹çš„æ—¶é—´ç‚¹è‡ªå‘æ˜¾ç°ï¼›ä½†å¯¹å¤§å¤šæ•°äººæ¥è¯´ï¼Œå®ƒä¿æŒç€ç¨³å®šçš„å­˜åœ¨æ„Ÿï¼Œéšç€è¯æ•ˆä¸Šå‡è€Œå¢å¼ºï¼Œå¹¶åœ¨è¾¾åˆ°å³°å€¼æ—¶è¾¾åˆ°æé™ã€‚åœ¨ä¸­é«˜å‰‚é‡çš„1P-LSDä¸‹ï¼Œè¿™ç§æ„Ÿè§‰é€šå¸¸æ¥è¿‘æœ€é«˜æ°´å¹³ï¼Œç”šè‡³å¯èƒ½è®©äººå› ä¸ºæ„‰æ‚¦çš„æ„Ÿè§‰è€ŒåŠ¨å¼¹ä¸å¾—å‘¢ã€‚
    *   **[èº¯ä½“æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)** - éœ€è¦æ³¨æ„çš„æ˜¯ï¼Œè¿™ç§æ•ˆæœä¸åƒ[å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æˆ–[å…±æƒ…å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)é‚£æ ·å¯ä»¥å¯é åœ°è¯±å¯¼ï¼Œè€Œä¸”åŒæ ·å®¹æ˜“æ¯«æ— ç†ç”±åœ°è¡¨ç°ä¸ºæåº¦çš„èº«ä½“ä¸é€‚ã€‚
*   **[è§¦è§‰å¢å¼º](/è¯æ•ˆ/è§¦è§‰æ•ˆåº”.md)** - åœ¨å¤§å¤šæ•°1P-LSDä½“éªŒä¸­ï¼Œå¢å¼ºçš„è§¦è§‰æ„Ÿå—é€šå¸¸ä»¥ä¸­ç­‰æ°´å¹³æŒç»­å­˜åœ¨ã€‚å¦‚æœè¾¾åˆ°äº†[8Açº§å‡ ä½•](/è¯æ•ˆ/å‡ ä½•.md)çŠ¶æ€ï¼Œé€šå¸¸ä¼šä¼´éšä¸€ç§å¼ºçƒˆçš„æ„Ÿè§‰ï¼Œå³çªç„¶æ„è¯†åˆ°å¹¶èƒ½åŒæ—¶æ„Ÿå—åˆ°å…¨èº«çš„æ¯ä¸€æ ¹ç¥ç»æœ«æ¢¢ã€‚
*   **[è€åŠ›å¢å¼º](/è¯æ•ˆ/è€åŠ›å¢å¼º.md)** - ä¸ä¼ ç»Ÿ[å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)äº§ç”Ÿçš„è€åŠ›å¢å¼ºç›¸æ¯”ï¼Œè¿™é€šå¸¸æ¯”è¾ƒæ¸©å’Œã€‚
*   **[é£Ÿæ¬²æŠ‘åˆ¶](/è¯æ•ˆ/é£Ÿæ¬²æŠ‘åˆ¶.md)**
*   **[èº¯ä½“æ§åˆ¶å¢å¼º](/è¯æ•ˆ/èº¯ä½“æ§åˆ¶å¢å¼º.md)**
*   **[æ’å°¿å›°éš¾](/è¯æ•ˆ/æ’å°¿å›°éš¾.md)**
*   **[è¿‡åº¦æ‰“å“ˆæ¬ ](/è¯æ•ˆ/è¿‡åº¦æ‰“å“ˆæ¬ .md)** - è¿™ç§æ•ˆæœæ¯”[èµ›æ´›è¥¿å®¾](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)åŠå…¶ç›¸å…³åŒ–åˆç‰©ï¼ˆå››ä½[å–ä»£è‰²èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)ï¼‰è¦æ˜æ˜¾å°‘è§å¾—å¤šã€‚
*   **[æ¶å¿ƒ](/è¯æ•ˆ/æ¶å¿ƒ.md)** - åœ¨ä¸­é«˜å‰‚é‡ä¸‹å¶å°”ä¼šæŠ¥å‘Šè½»å¾®çš„æ¶å¿ƒï¼Œé€šå¸¸åœ¨ç”¨æˆ·å‘•ååç«‹å³æ¶ˆå¤±ï¼Œæˆ–è€…éšç€å³°å€¼åˆ°æ¥è€Œè‡ªè¡Œé€æ¸æ¶ˆé€€ã€‚
*   **[è¡€å‹å‡é«˜](/è¯æ•ˆ/è¡€å‹å‡é«˜.md)**
*   **[å¿ƒç‡å¢å¿«](/è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)**
*   **[å‡ºæ±—å¢åŠ ](/è¯æ•ˆ/å‡ºæ±—å¢åŠ .md)**
*   **[è‚Œè‚‰æ”¶ç¼©](/è¯æ•ˆ/è‚Œè‚‰ç´§å¼ .md)**
*   **[è‚Œè‚‰ç—‰æŒ›](/è¯æ•ˆ/è‚Œè‚‰ç—‰æŒ›.md)**
*   **[ç³å­”æ‰©å¤§](/è¯æ•ˆ/ç³å­”æ‰©å¤§.md)**
*   **[å”¾æ¶²åˆ†æ³Œå¢åŠ ](/è¯æ•ˆ/æµå£æ°´.md)**
*   **[è¡€ç®¡æ”¶ç¼©](/è¯æ•ˆ/è¡€ç®¡æ”¶ç¼©.md)** - è¡€ç®¡æ”¶ç¼©å¯èƒ½ä¼šå¯¼è‡´ç”¨æˆ·æ„Ÿåˆ°å¯’å†·ï¼Œå°¤å…¶æ˜¯åœ¨å››è‚¢ã€‚
*   **[ç™«ç—«å‘ä½œ](/è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)** - è¿™ç§å¯èƒ½æ€§ä¸»è¦æ˜¯ä»[LSD](/è¯ç‰©/LSD.md)æŠ¥å‘Šçš„ç™«ç—«å‘ä½œä¸­æ¨æ–­å‡ºæ¥çš„ã€‚è¿™è¢«è®¤ä¸ºä¸»è¦æ˜¯åœ¨é‚£äº›æœ‰é—ä¼ å€¾å‘çš„äººèº«ä¸Šçš„é£é™©ï¼Œç‰¹åˆ«æ˜¯åœ¨ä¼´éšè„±æ°´ã€ç–²åŠ³ã€è¥å…»ä¸è‰¯æˆ–è¿‡çƒ­ç­‰èº«ä½“è´Ÿæ‹…é‡çš„æƒ…å†µä¸‹ã€‚

### **è§†è§‰æ•ˆåº”**

#### å¢å¼º
*   **[é¢œè‰²å¢å¼º](/è¯æ•ˆ/é¢œè‰²å¢å¼º.md)** - ä¸å…¶ä»–è¿·å¹»å‰‚ç›¸æ¯”ï¼Œè¿™ç§æ•ˆæœé€šå¸¸è¢«æŠ¥å‘Šä¸ºæ›´æ˜äº®ï¼Œä½†åœ¨ç‰¹å¾ä¸Šä¸é‚£ä¹ˆå¤šæ ·åŒ–ã€‚
*   **[æ¨¡å¼è¯†åˆ«å¢å¼º](/è¯æ•ˆ/æ¨¡å¼è¯†åˆ«å¢å¼º.md)**
*   **[è§†è§‰é”åº¦å¢å¼º](/è¯æ•ˆ/è§†è§‰é”åº¦å¢å¼º.md)**

#### æ‰­æ›²
*   **[æ¼‚ç§»](/è¯æ•ˆ/æ¼‚ç§».md)** *([èåŒ–](/è¯æ•ˆ/æ¼‚ç§».md)ã€[å‘¼å¸](/è¯æ•ˆ/æ¼‚ç§».md)ã€[å˜å½¢](/è¯æ•ˆ/æ¼‚ç§».md)å’Œ[æµåŠ¨](/è¯æ•ˆ/æ¼‚ç§».md))* - ä¸å…¶ä»–è¿·å¹»å‰‚ç›¸æ¯”ï¼Œè¿™ç§æ•ˆæœå¯ä»¥æè¿°ä¸ºé«˜åº¦è¯¦ç»†ä½†å¤–è§‚ä¸Šåƒå¡é€šä¸€æ ·ã€‚æ‰­æ›²åŠ¨ä½œç¼“æ…¢æµç•…ï¼Œå¤–è§‚ç¨çºµå³é€ã€‚
*   **[é¢œè‰²åç§»](/è¯æ•ˆ/é¢œè‰²åç§».md)**
*   **[é¢œè‰²æŸ“è‰²](/è¯æ•ˆ/é¢œè‰²æŸ“è‰².md)**
*   **[æ®‹å½±](/è¯æ•ˆ/æ®‹å½±.md)** (Tracers)
*   **[è§†è§‰æ®‹ç•™](/è¯æ•ˆ/æ®‹å½±.md)** (After images)
*   **[æ·±åº¦æ„ŸçŸ¥æ‰­æ›²](/è¯æ•ˆ/æ·±åº¦æ„ŸçŸ¥æ‰­æ›².md)**
*   **[é€è§†æ‰­æ›²](/è¯æ•ˆ/é€è§†æ‰­æ›².md)**
*   **[é€’å½’](/è¯æ•ˆ/é€’å½’.md)**
*   **[å¯¹ç§°çº¹ç†é‡å¤](/è¯æ•ˆ/å¯¹ç§°çº¹ç†é‡å¤.md)**
*   **[é£æ™¯åˆ‡ç‰‡](/è¯æ•ˆ/é£æ™¯åˆ‡ç‰‡.md)**

#### [å‡ ä½•](/è¯æ•ˆ/å‡ ä½•.md)
1P-LSDçš„è§†è§‰å‡ ä½•åœ¨å¤–è§‚ä¸Šå¯ä»¥æè¿°ä¸ºæ›´ç±»ä¼¼äº[2C-B](/è¯ç‰©/2C-B.md)æˆ–[2C-I](/è¯ç‰©/2C-I.md)ï¼Œè€Œä¸æ˜¯[èµ›æ´›è¾›](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)ã€[LSA](/è¯ç‰©/LSA.md)æˆ–[DMT](/è¯ç‰©/DMT.md)ã€‚å®ƒçš„[å˜ä½“](/è¯æ•ˆ/å‡ ä½•.md)å¯ä»¥å…¨é¢æè¿°ä¸ºï¼šå¤æ‚åº¦ç²¾ç»†ã€å½¢å¼ç®—æ³•åŒ–ã€ç»„ç»‡éç»“æ„åŒ–ã€å…‰çº¿æ˜äº®ã€è‰²å½©ä¸°å¯Œã€æ„Ÿè§‰åˆæˆã€é…è‰²å¤šå½©ã€é˜´å½±å¹³å¦ã€è¾¹ç¼˜é”åˆ©ã€å°ºå¯¸å·¨å¤§ã€é€Ÿåº¦å¿«ã€è¿åŠ¨å¹³æ»‘ã€è§’è½æœ‰æ£±è§’ã€æ·±åº¦éæ²‰æµ¸å¼ä¸”å¼ºåº¦ä¸€è‡´ã€‚

åœ¨é«˜çº§å‡ ä½•çš„æƒ…å†µä¸‹ï¼Œè¿™ç§ç‰©è´¨ä¸»è¦æ˜¯[8Açº§](/è¯æ•ˆ/å‡ ä½•.md)ï¼Œä½†åœ¨é€‚å½“çš„æƒ…å†µä¸‹ä¹Ÿèƒ½å¤Ÿè¯±å¯¼[8Bçº§å‡ ä½•](/è¯æ•ˆ/å‡ ä½•.md)ã€‚

#### å¹»è§‰çŠ¶æ€
1P-LSDèƒ½å¤Ÿäº§ç”Ÿå…¨æ–¹ä½çš„å¹»è§‰çŠ¶æ€ï¼Œå…¶æ–¹å¼æ˜æ˜¾ä¸å¦‚å…¶ä»–å¸¸ç”¨è¿·å¹»å‰‚ï¼ˆç‰¹åˆ«æ˜¯åƒ[DMT](/è¯ç‰©/DMT.md)æˆ–[èµ›æ´›è¥¿å®¾è˜‘è‡](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)è¿™æ ·çš„è‰²èƒºç±»ï¼‰é‚£æ ·ä¸€è‡´å’Œå¯é‡å¤ã€‚è¿™äº›æ•ˆæœåŒ…æ‹¬ï¼š

*   **[è½¬åŒ–](/è¯æ•ˆ/è½¬åŒ–.md)**
*   **[æœºæ¢°æ™¯è§‚](/è¯æ•ˆ/æœºæ¢°æ™¯è§‚.md)** - è¿™æ˜¯ä¸€ä¸ªç½•è§çš„æ•ˆæœï¼Œé€šå¸¸åªå‘ç”Ÿåœ¨éå¸¸å¼ºåˆ°ä¸¥é‡çš„å‰‚é‡ä¸‹ï¼Œè€Œä¸”ä¸åƒ[DMT](/è¯ç‰©/DMT.md)ã€[ETH-LAD](/è¯ç‰©/ETH-LAD.md)å’Œ[2C-P](/è¯ç‰©/2C-P.md)ç­‰æ˜¾è‘—è§†è§‰è¿·å¹»å‰‚ä»¥åŠåƒ[é¼ å°¾è‰](/è¯ç‰©/é¼ å°¾è‰.md)è¿™æ ·çš„éå…¸å‹è¿·å¹»å‰‚é‚£æ ·ä¸€è‡´ã€‚
*   **[å†…éƒ¨å¹»è§‰](/è¯æ•ˆ/å†…éƒ¨å¹»è§‰.md)** (*[è‡ªä¸»å®ä½“](/è¯æ•ˆ/è‡ªä¸»å®ä½“.md)*ï¼›*[åœºæ™¯ã€é£æ™¯å’Œæ™¯è§‚](/è¯æ•ˆ/åœºæ™¯.md)*ï¼›*[é€è§†å¹»è§‰](/è¯æ•ˆ/é€è§†å¹»è§‰.md)*å’Œ*[æƒ…æ™¯ä¸æƒ…èŠ‚](/è¯æ•ˆ/æƒ…æ™¯ä¸æƒ…èŠ‚.md)*) - è™½ç„¶æŠ€æœ¯ä¸Š1P-LSDèƒ½å¤Ÿäº§ç”Ÿåœ¨ç”ŸåŠ¨æ€§å’Œå¼ºåº¦ä¸Šä¸[èµ›æ´›è¾›](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)æˆ–[DMT](/è¯ç‰©/DMT.md)ç›¸å½“çš„å¹»è§‰çŠ¶æ€ï¼Œä½†è¿™äº›æ•ˆæœç›¸æ¯”ä¹‹ä¸‹æå…¶ç½•è§ä¸”ä¸ä¸€è‡´ã€‚è™½ç„¶ä¼ ç»Ÿçš„è¿·å¹»å‰‚å¦‚[LSA](/è¯ç‰©/LSA.md)ã€[æ­»è—¤æ°´](/è¯ç‰©/æ­»è—¤æ°´.md)å’Œ[éº¦æ–¯å¡æ—](/è¯ç‰©/éº¦æ–¯å¡æ—.md)ä¼šåœ¨5çº§[å‡ ä½•](/è¯æ•ˆ/å‡ ä½•.md)åŠä»¥ä¸Šå‡ ä¹ä¸€è‡´åœ°è¯±å¯¼å†…éƒ¨å¹»è§‰ï¼Œä½†1P-LSDå¯¹å¤§å¤šæ•°äººæ¥è¯´åªä¼šç›´æ¥è¿›å…¥[8Açº§](/è¯æ•ˆ/å‡ ä½•.md)è§†è§‰å‡ ä½•ã€‚è¿™ç§ç¼ºä¹ä¸€è‡´è¯±å¯¼çš„å¹»è§‰çªç ´æ„å‘³ç€å¯¹äºå¤§å¤šæ•°äººæ¥è¯´ï¼ŒLSDåœ¨æ·±åº¦ä¸Šæ˜¯æœ‰é™çš„ã€‚å½“å®ƒä»¬å‘ç”Ÿæ—¶ï¼Œå¯ä»¥æ ¹æ®å…¶[å˜ä½“](/è¯æ•ˆ/å†…éƒ¨å¹»è§‰.md)æè¿°ä¸ºï¼šå¯ä¿¡åº¦æ¸…æ™°ã€é£æ ¼äº’åŠ¨ã€å†…å®¹æ–°é¢–ã€å¯æ§æ€§è‡ªä¸»ä¸”å¤–è§‚åŸºäº[å‡ ä½•](/è¯æ•ˆ/å‡ ä½•.md)ã€‚
*   **[å¤–éƒ¨å¹»è§‰](/è¯æ•ˆ/å¤–éƒ¨å¹»è§‰.md)** (*[è‡ªä¸»å®ä½“](/è¯æ•ˆ/è‡ªä¸»å®ä½“.md)*ï¼›*[åœºæ™¯ã€é£æ™¯å’Œæ™¯è§‚](/è¯æ•ˆ/åœºæ™¯.md)*ï¼›*[é€è§†å¹»è§‰](/è¯æ•ˆ/é€è§†å¹»è§‰.md)*å’Œ*[æƒ…æ™¯ä¸æƒ…èŠ‚](/è¯æ•ˆ/æƒ…æ™¯ä¸æƒ…èŠ‚.md)*)

### **è®¤çŸ¥æ•ˆåº”**

*   **[åˆ†æå¢å¼º](/è¯æ•ˆ/åˆ†æå¢å¼º.md)** - è¿™ç§æ•ˆæœåœ¨æ˜¾ç°ä¸Šæ˜¯ä¸€è‡´çš„ï¼Œä¸”ä»¥[å†…çœ](/è¯æ•ˆ/å†…çœå¢å¼º.md)ä¸ºä¸»å¯¼ã€‚
*   **[ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)** & **[åæ‰§](/è¯æ•ˆ/åæ‰§.md)** - è¿™ç§æ•ˆæœåœ¨ä½åˆ°ä¸­ç­‰å‰‚é‡ä¸‹ä¸å¸¸è§ï¼Œå¦‚æœè€ƒè™‘äº†[æƒ…æ™¯ä¸å¿ƒå¢ƒ](/æ–‡æ¡£/æƒ…æ™¯ä¸å¿ƒå¢ƒ.md)çš„åŸºæœ¬è§„åˆ™ï¼Œå‘ç”Ÿçš„å¯èƒ½æ€§å°±æ›´å°äº†ã€‚éœ€è¦æ³¨æ„çš„æ˜¯ï¼Œè¿™ç§ä¸ä¸€è‡´è¯±å‘çš„æ•ˆæœä¼¼ä¹åœ¨ä½¿ç”¨[å¤§éº»](/è¯ç‰©/å¤§éº».md)æ—¶æ›´æœ‰å¯èƒ½æ˜¾ç°ã€‚å¦‚æœä¸ç†Ÿæ‚‰è¿·å¹»å‰‚ï¼Œåº”æå…¶è°¨æ…åœ°ä½¿ç”¨è¿™ç§ç»„åˆï¼Œè¿™æ„å‘³ç€ç”¨æˆ·åº”è¯¥é€‚å½“åœ°è°ƒæ•´èŠ‚å¥ï¼Œåªä½¿ç”¨å¹³æ—¶é‡çš„ä¸€å°éƒ¨åˆ†ã€‚é€šå¸¸æŠ¥å‘Šç§°ï¼Œè¿·å¹»å‰‚å¯ä»¥åœ¨ä¸€å®šç¨‹åº¦ä¸ŠæŠµæ¶ˆTHCçš„ä¸€äº›æ„ŸçŸ¥åˆ°çš„ç²¾ç¥æµ‘æµŠæˆ–ä¸­æ¯’æ•ˆæœï¼Œå¯¼è‡´ç”¨æˆ·åè¿‡æ¥ä½¿ç”¨æ¯”éœ€è¦æ›´å¤šçš„å¤§éº»ï¼Œè¿™é€šå¸¸ä¼šå¯¼è‡´å‹å€’æ€§çš„ç„¦è™‘å¿ƒæ€æˆ–["æ¶æ€§æ—…ç¨‹"](/æ–‡æ¡£/æ¶æ€§æ—…ç¨‹.md)ã€‚
*   **[å®£æ³„](/è¯æ•ˆ/å®£æ³„.md)**
*   **[æ¦‚å¿µæ€§æ€ç»´](/è¯æ•ˆ/æ¦‚å¿µæ€§æ€ç»´.md)**
*   **[åˆ›é€ åŠ›å¢å¼º](/è¯æ•ˆ/åˆ›é€ åŠ›å¢å¼º.md)**
*   **[æƒ…ç»ªå¢å¼º](/è¯æ•ˆ/æƒ…ç»ªå¢å¼º.md)**
*   **[æ–°å¥‡æ„Ÿå¢å¼º](/è¯æ•ˆ/æ–°å¥‡æ„Ÿå¢å¼º.md)**
*   **[ä¸ªäººåè§æŠ‘åˆ¶](/è¯æ•ˆ/ä¸ªäººåè§æŠ‘åˆ¶.md)**
*   **[ä¸ªäººæ„ä¹‰å¢å¼º](/è¯æ•ˆ/ä¸ªäººæ„ä¹‰å¢å¼º.md)**
*   **[ä¸“æ³¨åŠ›å¢å¼º](/è¯æ•ˆ/ä¸“æ³¨åŠ›å¢å¼º.md)** - è¿™ç§æ•ˆæœä»…åœ¨ä½æˆ–[é˜ˆå€¼](/æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#é˜ˆå€¼)å‰‚é‡ä¸‹ä½“éªŒï¼Œæ„Ÿè§‰æ¯”[å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æ›´ä¸å¼ºè¿«ã€‚
*   **[æ²‰æµ¸æ„Ÿå¢å¼º](/è¯æ•ˆ/æ²‰æµ¸æ„Ÿå¢å¼º.md)**
*   **[æš—ç¤ºæ€§å¢å¼º](/è¯æ•ˆ/æš—ç¤ºæ€§å¢å¼º.md)**
*   **[è®¤çŸ¥æ¬£å¿«](/è¯æ•ˆ/è®¤çŸ¥æ¬£å¿«.md)** - ä¸€èˆ¬æ¥è¯´ï¼Œè¿™ç§æˆåˆ†ä¸å¦‚[èµ›æ´›è¥¿å®¾](/è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)å’Œ[MDMA](/è¯ç‰©/MDMA.md)é‚£æ ·ä¸€è‡´å’Œæ˜æ˜¾ã€‚LSDå¸¦æ¥çš„ç²¾ç¥æ¬£å¿«æ„Ÿé€šå¸¸ä»…ä»…æ˜¯å› ä¸ºå¢å¼ºäº†ç”¨æˆ·å½“å‰çš„å¿ƒç†å’Œæƒ…æ„ŸçŠ¶æ€ï¼Œå†åŠ ä¸Šå…¶æ›´å¸¸å‘ç”Ÿçš„[èº¯ä½“æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)æ•ˆæœã€‚
*   **[å¦„æƒ³](/è¯æ•ˆ/å¦„æƒ³.md)**
*   **[æ—¢è§†æ„Ÿ](/è¯æ•ˆ/æ—¢è§†æ„Ÿ.md)**
*   **[è‡ªæˆ‘æ›¿ä»£](/è¯æ•ˆ/è‡ªæˆ‘æ›¿ä»£.md)**
*   **[æ€§æ¬²å¢å¼º](/è¯æ•ˆ/æ€§æ¬²å¢å¼º.md)**
*   **[éŸ³ä¹æ¬£èµå¢å¼º](/è¯æ•ˆ/éŸ³ä¹æ¬£èµå¢å¼º.md)**
*   **[å¹½é»˜æ„Ÿå¢å¼º](/è¯æ•ˆ/å¹½é»˜æ„Ÿå¢å¼º.md)**
    *   **[ç‹‚ç¬‘](/è¯æ•ˆ/ç‹‚ç¬‘.md)** - è¿™å¯èƒ½åœ¨1P-LSDä½“éªŒä¸­æ˜¾è‘—è¡¨ç°å‡ºæ¥ï¼Œç‰¹åˆ«æ˜¯åœ¨[è¯æ•ˆä¸Šå‡](/æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆä¸Šå‡)é˜¶æ®µï¼Œç»å¸¸å¯¼è‡´æ— æ³•æ§åˆ¶çš„å’¯å’¯ç¬‘å’Œå¤§ç¬‘ï¼Œå¦‚æœå‘¨å›´æœ‰å…¶ä»–äººä¹Ÿåœ¨å—å½±å“ï¼Œå¯èƒ½ä¼šå½¢æˆåé¦ˆå¾ªç¯ã€‚
*   **[è®°å¿†æŠ‘åˆ¶](/è¯æ•ˆ/è®°å¿†æŠ‘åˆ¶.md)**
    *   **[è‡ªæˆ‘æ­»](/è¯æ•ˆ/è‡ªæˆ‘æ­».md)**
*   **[æ€ç»´åŠ é€Ÿ](/è¯æ•ˆ/æ€ç»´åŠ é€Ÿ.md)**
*   **[æ€ç»´è§£ä½“](/è¯æ•ˆ/æ€ç»´è§£ä½“.md)**
*   **[æ€ç»´å¾ªç¯](/è¯æ•ˆ/æ€ç»´å¾ªç¯.md)**
*   **[æ—¶é—´æ‰­æ›²](/è¯æ•ˆ/æ—¶é—´æ‰­æ›².md)**
*   **[æ¸…é†’](/è¯æ•ˆ/æ¸…é†’.md)**

### **å¬è§‰æ•ˆåº”**

*   **[å¬è§‰å¢å¼º](/è¯æ•ˆ/å¬è§‰å¢å¼º.md)**
*   **[å¬è§‰æ‰­æ›²](/è¯æ•ˆ/å¬è§‰æ‰­æ›².md)**
*   **[å¬è§‰å¹»è§‰](/è¯æ•ˆ/å¬è§‰å¹»è§‰.md)**

### **å¤šæ„Ÿå®˜æ•ˆåº”**

*   **[è”è§‰](/è¯æ•ˆ/è”è§‰.md)** - åœ¨å…¶æœ€å……åˆ†çš„è¡¨ç°ä¸­ï¼Œè¿™æ˜¯ä¸€ç§éå¸¸ç½•è§ä¸”ä¸å¯å¤åˆ¶çš„æ•ˆæœã€‚å¢åŠ å‰‚é‡å¯ä»¥å¢åŠ è¿™ç§æƒ…å†µå‘ç”Ÿçš„å¯èƒ½æ€§ï¼Œä½†ä¼¼ä¹åªæœ‰åœ¨é‚£äº›å·²ç»å€¾å‘äºè”è§‰çŠ¶æ€çš„äººç¾¤ä¸­æ‰æ˜¯ä½“éªŒçš„é‡è¦ç»„æˆéƒ¨åˆ†ã€‚

### **[è¶…ä¸ªäºº](/è¯æ•ˆ/è¶…ä¸ªäºº.md)æ•ˆåº”**

*   **[çµæ€§å¢å¼º](/è¯æ•ˆ/çµæ€§å¢å¼º.md)**
*   **[å­˜åœ¨ä¸»ä¹‰è‡ªæˆ‘å®ç°](/è¯æ•ˆ/å­˜åœ¨ä¸»ä¹‰è‡ªæˆ‘å®ç°.md)**
*   **[ç»Ÿä¸€æ„Ÿå’Œç›¸äº’è”ç³»æ„Ÿ](/è¯æ•ˆ/ç»Ÿä¸€æ„Ÿå’Œç›¸äº’è”ç³»æ„Ÿ.md)**

### è¯ç‰©è”ç”¨

*   **[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)** - é…’ç²¾çš„ä¸­æ¢æŠ‘åˆ¶ä½œç”¨å¯ä»¥ç”¨æ¥å‡å°‘1P-LSDäº§ç”Ÿçš„ä¸€äº›ç„¦è™‘å’Œç´§å¼ ã€‚ç„¶è€Œï¼Œé…’ç²¾ä¼šå¯¼è‡´[è„±æ°´](/è¯æ•ˆ/è„±æ°´.md)ã€[æ¶å¿ƒ](/è¯æ•ˆ/æ¶å¿ƒ.md)å’Œ[èº¯ä½“ç–²åŠ³](/è¯æ•ˆ/èº¯ä½“ç–²åŠ³.md)ï¼Œè¿™å¯èƒ½ä¼šå¯¹æ—…ç¨‹çš„æ–¹å‘äº§ç”Ÿè´Ÿé¢å½±å“ã€‚å»ºè®®ç”¨æˆ·è°ƒæ•´èŠ‚å¥ï¼Œåªå–å¹³æ—¶é‡çš„ä¸€å°éƒ¨åˆ†å“¦ã€‚
*   **[è‹¯äºŒæ°®å“ç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‹¯äºŒæ°®å“ç±»ç‰©è´¨.md)** - è‹¯äºŒæ°®å“ç±»ç‰©è´¨é€šè¿‡æ™®éæŠ‘åˆ¶å¤§è„‘æ´»åŠ¨ï¼Œéå¸¸æœ‰æ•ˆåœ°é™ä½1P-LSDæ•ˆæœçš„å¼ºåº¦ã€‚
*   **[å¤§éº»](/è¯ç‰©/å¤§éº».md)** - ğŸ’” å¤§éº»å¼ºçƒˆå¢å¼º1P-LSDçš„æ„Ÿå®˜å’Œè®¤çŸ¥æ•ˆæœã€‚ä½¿ç”¨è¿™ç§ç»„åˆæ—¶å»ºè®®**æåº¦è°¨æ…**ï¼Œå› ä¸ºå®ƒå¯ä»¥æ˜¾è‘—å¢åŠ ä¸è‰¯å¿ƒç†ååº”çš„æœºä¼šï¼Œå¦‚[ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)ã€[å›°æƒ‘](/è¯æ•ˆ/å›°æƒ‘.md)å’Œ[ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—…å‘ä½œ.md)ã€‚å»ºè®®ç”¨æˆ·ä»å¹³æ—¶å¤§éº»å‰‚é‡çš„ä¸€å°éƒ¨åˆ†å¼€å§‹ï¼Œå¹¶åœ¨æ¯ä¸€å£ä¹‹é—´é•¿æ—¶é—´ä¼‘æ¯ï¼Œä»¥é¿å…æ‘„å…¥è¿‡é‡ã€‚
*   **[è§£ç¦»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§£ç¦»å‰‚.md)** - 1P-LSDå¢å¼ºè§£ç¦»å‰‚çš„è®¤çŸ¥ã€è§†è§‰å’Œä¸€èˆ¬å¹»è§‰æ•ˆæœã€‚è§£ç¦»å‰‚è¯±å¯¼çš„[å­”æ´ã€ç©ºé—´å’Œè™šç©º](/è¯æ•ˆ/è§†è§‰æ–­å¼€.md)ä»¥åŠ[å†…éƒ¨å¹»è§‰](/è¯æ•ˆ/å†…éƒ¨å¹»è§‰.md)åœ¨1P-LSDçš„ä½œç”¨ä¸‹å˜å¾—æ›´åŠ ç”ŸåŠ¨å’Œå¼ºçƒˆã€‚è¿™äº›æ•ˆæœå¯¹åº”ç€[å›°æƒ‘](/è¯æ•ˆ/å›°æƒ‘.md)ã€[å¦„æƒ³](/è¯æ•ˆ/å¦„æƒ³.md)å’Œ[ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—…å‘ä½œ.md)é£é™©çš„å¢åŠ ã€‚
*   **[MDMA](/è¯ç‰©/MDMA.md)** - 1P-LSDå’ŒMDMAå…·æœ‰é«˜åº¦ååŒä½œç”¨ï¼Œç›¸äº’å¢å¼ºå¯¹æ–¹çš„èº«ä½“ã€è®¤çŸ¥å’Œè§†è§‰æ•ˆæœã€‚è¿™äº›ç‰©è´¨ä¹‹é—´çš„ååŒä½œç”¨æ˜¯ä¸å¯é¢„æµ‹çš„ï¼Œå»ºè®®ä»æ¯”å•ç‹¬æœç”¨æ¯ç§ç‰©è´¨æ—¶æ˜æ˜¾æ›´ä½çš„å‰‚é‡å¼€å§‹ã€‚æœ‰ä¸€äº›è¯æ®è¡¨æ˜LSDä¼šå¢åŠ MDMAçš„ç¥ç»æ¯’æ€§ï¼Œè¿™å¯èƒ½ä¹Ÿä¸1P-LSDæœ‰å…³å“¦ã€‚
*   **[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)** - å½“ä¸å…¶ä»–è¿·å¹»å‰‚ç»“åˆä½¿ç”¨æ—¶ï¼Œ1P-LSDçš„èº«ä½“ã€è®¤çŸ¥ã€è§†è§‰ã€å¬è§‰å’Œè¶…ä¸ªäººæ•ˆæœä¼šå¼ºçƒˆå¢å¼ºå’ŒååŒã€‚å¦‚æœé€‰æ‹©æ··åˆè¿·å¹»å‰‚ï¼Œå»ºè®®ä»æ¯”å•ç‹¬æœç”¨ä»»ä½•ä¸€ç§ç‰©è´¨æ—¶æ˜æ˜¾æ›´ä½çš„å‰‚é‡å¼€å§‹ã€‚
*   **[å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** - ä¸è¿·å¹»å‰‚ç»“åˆä½¿ç”¨æ—¶ï¼Œå…´å¥‹å‰‚å¯èƒ½ä¼šå¯¼è‡´ä¸¥é‡çš„**[ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)**ã€**[ææ…Œå‘ä½œ](/è¯æ•ˆ/ææ…Œå‘ä½œ.md)**ã€**[æ€ç»´å¾ªç¯](/è¯æ•ˆ/æ€ç»´å¾ªç¯.md)**å’Œ**[åæ‰§](/è¯æ•ˆ/åæ‰§.md)**ã€‚

### ä½“éªŒæŠ¥å‘Š

æè¿°æ­¤åŒ–åˆç‰©åœ¨æˆ‘ä»¬[ä½“éªŒç´¢å¼•](/æŠ¥å‘Š/psychounautwiki/home.md)ä¸­æ•ˆæœçš„è½¶äº‹æŠ¥å‘ŠåŒ…æ‹¬ï¼š

*   [ä½“éªŒï¼š1 tab 1P-LSD (å£æœ) - åœ¨æ£®æ—ä¸­å‘ç°è‡ªå·±](/æŠ¥å‘Š/psychounautwiki/Experience_1_tab_1P-LSD_(oral)_-_Finding_myself_within_the_forest.md)
*   [ä½“éªŒï¼š200Âµg 1P-LSD (èˆŒä¸‹) + 12mg CBD - åŒç†å¿ƒçš„æ¼©æ¶¡](/æŠ¥å‘Š/psychounautwiki/Experience_200Âµg_1P-LSD_(sublingual)_+_12mg_CBD_-_The_Vortex_of_Empathy.md)
*   [ä½“éªŒï¼š200Î¼g 1P-LSD (å£æœ) - æä¹å¤©å ‚](/æŠ¥å‘Š/psychounautwiki/Experience_200Î¼g_1P-LSD_(oral)_-_Blissful_Paradise.md)
*   [ä½“éªŒï¼š22mg 2C-B (å£æœ) / 100ug 1P-LSD (èˆŒä¸‹) - æˆ‘ç¬¬ä¸€æ¬¡ç‹¬è‡ªæ—…è¡Œï¼ˆè¿ç»­2å¤©ï¼‰](/æŠ¥å‘Š/psychounautwiki/Experience_22mg_2C-B_(oral)_/_100ug_1P-LSD_(sublingual)_-_My_first_time_tripping_alone_(2_days_in_a_row).md)
*   [ä½“éªŒï¼š100ug 1P-LSD (å£æœ) + å¤§éº» - è‡ªæˆ‘å®ç°](/æŠ¥å‘Š/psychounautwiki/Experience_100ug_1P-LSD_(Oral)_+_Cannabis_-_Self_Realizations.md)
*   [ä½“éªŒï¼š100ug 1P-LSD - ä»ææƒ§å’ŒåŒæ¶åˆ°æä¹](/æŠ¥å‘Š/psychounautwiki/Experience_100ug_1P-LSD_-_A_Fear_and_loathing_into_Bliss.md)
*   [ä½“éªŒï¼š150Î¼g tab 1P-LSD (å£æœ) - æƒŠäººä¸”éå¸¸æ¼«é•¿çš„æ—…ç¨‹ (20+ å°æ—¶)](/æŠ¥å‘Š/psychounautwiki/Experience_150Î¼g_tab_1P-LSD_(oral)_-_Amazing_and_very_long_trip_(20+_hours).md)
*   [ä½“éªŒï¼š1P-LSD (300 ug) - ç”Ÿæ´»åœ¨ä¸€ä¸ªå……æ»¡çˆ±çš„æ¨¡æ‹Ÿä¸­](/æŠ¥å‘Š/psychounautwiki/Experience_1P-LSD_(300_ug)_-_Living_in_a_simulation_filled_with_love.md)
*   [ä½“éªŒï¼š1P-LSD (500ug, tabs) - æ— é™ç»Ÿä¸€](/æŠ¥å‘Š/psychounautwiki/Experience_1P-LSD_(500ug,_tabs)_-_Infinite_Unity.md)
*   [ä½“éªŒï¼š300ug 1P-LSD (å£æœ) - å½©è™¹ç®¡å’Œä¸äººç±»åˆä¸€](/æŠ¥å‘Š/psychounautwiki/Experience_300ug_1P-LSD_(Oral)_-_Rainbow_Tubes_and_Becoming_One_With_Humanity.md)
*   [ä½“éªŒï¼š300Î¼g 1P-LSD + 40mg äºŒè‹¯å•¶ - æˆ‘ç¬¬ä¸€æ¬¡ç²¾ç¥ç—…å‘ä½œ](/æŠ¥å‘Š/psychounautwiki/Experience_300Î¼g_1P-LSD_+_40mg_diphenidine_-_My_first_psychotic_break.md)

å…¶ä»–çš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

*   [Erowid Experience Vaults: 1P-LSD](https://www.erowid.org/experiences/subs/exp_1PLSD.shtml)

## æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›

> ğŸš‘ **è¿™ä¸€éƒ¨åˆ†è¿˜æ˜¯ä¸ªå°è‹—è‹—...**
>
> ç»“æœå¯èƒ½åŒ…å«ä¸å®Œæ•´ç”šè‡³**å±é™©çš„é”™è¯¯**ä¿¡æ¯ï¼ä½ å¯ä»¥é€šè¿‡ç¼–è¾‘æ¥å¸®åŠ©[æ‰©å±•æˆ–æ›´æ­£å®ƒ](/home.md)ã€‚
>
> *æ³¨æ„ï¼šå¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œè¯·åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶å¹¶ä½¿ç”¨**[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)**ã€‚*

å¦è§ï¼š[ç ”ç©¶ç”¨åŒ–å­¦å“ Â§ æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md#æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›)ï¼Œä»¥åŠ[è´Ÿè´£ä»»çš„ç”¨è¯ Â§ è‡´å¹»å‰‚](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)

1P-LSDå¨±ä¹æ€§ä½¿ç”¨çš„æ¯’æ€§å’Œé•¿æœŸå¥åº·å½±å“è¿˜æ²¡æœ‰è¢«ç ”ç©¶è¿‡å“¦ã€‚è¿™æ˜¯å› ä¸º1P-LSDæ˜¯ä¸€ç§[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ï¼Œå‡ ä¹æ²¡æœ‰ä»»ä½•äººç±»ä½¿ç”¨å†å²ã€‚

è½¶äº‹æŠ¥å‘Šè¡¨æ˜ï¼Œä»…ä»…å•ç‹¬å°è¯•1P-LSDï¼Œåœ¨ä½åˆ°ä¸­ç­‰å‰‚é‡ä¸‹ï¼Œå¹¶ä¸”éå¸¸èŠ‚åˆ¶åœ°ä½¿ç”¨ï¼Œä¼¼ä¹æ²¡æœ‰è´Ÿé¢å¥åº·å½±å“ï¼ˆè™½ç„¶æ²¡æœ‰ä»€ä¹ˆèƒ½å®Œå…¨ä¿è¯å•¦ï¼‰ã€‚åœ¨æ¶ˆè´¹å‰ï¼Œæ€»æ˜¯åº”è¯¥è¿›è¡Œ[ç‹¬ç«‹ç ”ç©¶](https://www.google.com/)ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚

åŸºäºå®ƒä¸LSDçš„ç›¸ä¼¼æ€§ï¼Œå‡è®¾1P-LSDåœ¨ç”Ÿç†ä¸Šå…·æœ‰è‰¯å¥½çš„è€å—æ€§ï¼Œç›¸å¯¹äºå‰‚é‡çš„æ¯’æ€§æä½ã€‚æ€¥æ€§1P-LSDæš´éœ²åæŠ¥å‘Šçš„èº«ä½“å‰¯ä½œç”¨ç›¸å¯¹è¾ƒå°‘ã€‚

ç„¶è€Œï¼Œå°±åƒLSDå’Œä¸€èˆ¬è¿·å¹»å‰‚ä¸€æ ·ï¼Œ1P-LSDå¯èƒ½ä¼šæˆä¸ºé‚£äº›æœ‰æ½œåœ¨ç²¾ç¥éšœç¢çš„äººçš„è¯±å› ã€‚é€šå¸¸å»ºè®®é‚£äº›æœ‰ç²¾ç¥ç–¾ç—…ä¸ªäººå²æˆ–å®¶æ—å²çš„äººä¸è¦ä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œå°¤å…¶æ˜¯åœ¨æ²¡æœ‰ç›‘ç£çš„åŒ»ç–—ç¯å¢ƒä¹‹å¤–ã€‚

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨è¿™ç§ç‰©è´¨æ—¶é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

### è¯ç‰©è¿‡é‡

1P-LSDæ²¡æœ‰å·²çŸ¥çš„æ¯’æ€§å‰‚é‡ã€‚ç„¶è€Œï¼Œè¾ƒé«˜å‰‚é‡ä¼šå¢åŠ ä¸è‰¯å¿ƒç†ååº”çš„é£é™©ã€‚è¿™äº›ååº”åŒ…æ‹¬[ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)ã€[å¦„æƒ³](/è¯æ•ˆ/å¦„æƒ³.md)ã€[ææ…Œå‘ä½œ](/è¯æ•ˆ/ææ…Œå‘ä½œ.md)ä»¥åŠæ›´ç½•è§çš„[ç™«ç—«å‘ä½œ](/è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)ã€‚é™¤éå‘ç”Ÿä¸¥é‡çš„ç²¾ç¥ç—…å‘ä½œæˆ–æ‘„å…¥äº†[å‡é…¸](/æ–‡æ¡£/æœªçŸ¥æˆåˆ†ç­–åˆ’è¯çš„å±å®³.md)ï¼ˆå¦‚[25I-NBOMe](/è¯ç‰©/25I-NBOMe.md)æˆ–[DOB](/è¯ç‰©/DOB.md)ï¼‰ï¼Œå¦åˆ™é€šå¸¸ä¸éœ€è¦åŒ»ç–—æ•‘åŠ©ã€‚ç»™äºˆ[è‹¯äºŒæ°®å“ç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‹¯äºŒæ°®å“ç±»ç‰©è´¨.md)æˆ–[æŠ—ç²¾ç¥ç—…è¯](/æ–‡æ¡£/æŠ—ç²¾ç¥ç—…è¯.md)æœ‰åŠ©äºç¼“è§£1P-LSDçš„æ€¥æ€§è´Ÿé¢è®¤çŸ¥æ•ˆæœã€‚

### ä¾èµ–æ€§å’Œæ»¥ç”¨æ½œåŠ›

è™½ç„¶æ²¡æœ‰è¿›è¡Œæ­£å¼ç ”ç©¶ï¼Œä½†å‡è®¾åƒLSDæœ¬èº«ä¸€æ ·ï¼Œ1P-LSDæ²¡æœ‰æˆç˜¾æ€§ï¼Œæ»¥ç”¨æ½œåŠ›ä¹Ÿå¾ˆä½ã€‚æ²¡æœ‰æ–‡çŒ®æŠ¥å‘ŠæˆåŠŸè®­ç»ƒåŠ¨ç‰©è‡ªæˆ‘ç»™è¯LSDâ€”â€”è¿™æ˜¯ä¸€ç§é¢„æµ‹æ»¥ç”¨å€¾å‘çš„åŠ¨ç‰©æ¨¡å‹â€”â€”è¡¨æ˜å®ƒä¸å…·å¤‡å¼•å‘æˆ–ç»´æŒä¾èµ–æ‰€éœ€çš„è¯ç†å­¦ç‰¹æ€§ã€‚åŒæ ·ï¼Œåœæ­¢é•¿æœŸä½¿ç”¨LSDåå‡ ä¹æ²¡æœ‰æˆ’æ–­ç»¼åˆç—‡ã€‚å‡è®¾1P-LSDä¸LSDå…·æœ‰è¿™äº›ç›¸åŒçš„ç‰¹æ€§ã€‚

å¯¹1P-LSDæ•ˆæœçš„è€å—æ€§åœ¨æ‘„å…¥åå‡ ä¹ç«‹å³å»ºç«‹ã€‚ä¹‹åï¼Œå¤§çº¦éœ€è¦5-7å¤©è€å—æ€§æ‰ä¼šå‡åŠï¼Œ14å¤©æ‰èƒ½æ¢å¤åˆ°åŸºçº¿ï¼ˆåœ¨æ²¡æœ‰è¿›ä¸€æ­¥æ¶ˆè´¹çš„æƒ…å†µä¸‹ï¼‰ã€‚1P-LSDä¸æ‰€æœ‰[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)äº§ç”Ÿäº¤å‰è€å—ï¼Œè¿™æ„å‘³ç€åœ¨ä½¿ç”¨1P-LSDåï¼Œå®ƒä»¬çš„æ•ˆæœä¼šå‡å¼±ã€‚

### å±é™©çš„ç›¸äº’ä½œç”¨

> **âš ï¸ è­¦å‘Š**ï¼šè®¸å¤šç²¾ç¥æ´»æ€§ç‰©è´¨å•ç‹¬ä½¿ç”¨æ—¶ç›¸å½“å®‰å…¨ï¼Œä½†ä¸æŸäº›å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶å¯èƒ½ä¼šçªç„¶å˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä»¥ä¸‹åˆ—è¡¨æä¾›äº†ä¸€äº›å·²çŸ¥çš„å±é™©ç›¸äº’ä½œç”¨ï¼ˆå°½ç®¡ä¸ä¿è¯åŒ…å«æ‰€æœ‰ï¼‰ã€‚
>
> *è¯·åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶ï¼ˆä¾‹å¦‚ [Google](https://www.google.com), [DuckDuckGo](https://www.duckduckgo.com), [PubMed](https://pubmed.ncbi.nlm.nih.gov/)ï¼‰ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚ä¸€äº›åˆ—å‡ºçš„ç›¸äº’ä½œç”¨æ¥è‡ª [TripSit](https://combo.tripsit.me)ã€‚*

ä»¥ä¸‹ç‰©è´¨æ˜¯åŸºäºå‡è®¾1P-LSDæ‹¥æœ‰ä¸[LSD](/è¯ç‰©/LSD.md)ç›¸ä¼¼ç”šè‡³ç›¸åŒçš„å±é™©ç›¸äº’ä½œç”¨æ¦‚å†µè€Œåˆ—å‡ºçš„ï¼Œå¹¶ä¸”ç”±äºå…¶ä½œä¸ºæœªç ”ç©¶çš„[ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)çš„åœ°ä½ï¼Œå¯èƒ½åŒ…å«æ›´å¤šã€‚

*   **â›” [é”‚](http://en.wikipedia.org/wiki/Lithium_(medication))** - é”‚é€šå¸¸ç”¨äºæ²»ç–—åŒç›¸æƒ…æ„Ÿéšœç¢ã€‚æœ‰å¤§é‡çš„è½¶äº‹è¯æ®è¡¨æ˜ï¼Œå°†å…¶ä¸[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ä¸€èµ·æœç”¨ä¼šæ˜¾è‘—å¢åŠ [ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—…å‘ä½œ.md)å’Œ[ç™«ç—«å‘ä½œ](/è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)çš„é£é™©ã€‚å› æ­¤ï¼Œä¸¥ç¦ä½¿ç”¨è¿™ç§ç»„åˆã€‚
*   **ğŸ’” [å¤§éº»](/è¯ç‰©/å¤§éº».md)** - å¤§éº»å¯èƒ½ä¸1P-LSDçš„æ•ˆæœäº§ç”Ÿæ„æƒ³ä¸åˆ°çš„å¼ºçƒˆä¸”ä¸å¯é¢„æµ‹çš„ååŒä½œç”¨ã€‚å»ºè®®è°¨æ…ä½¿ç”¨è¿™ç§ç»„åˆï¼Œå› ä¸ºå®ƒä¼šæ˜¾è‘—å¢åŠ ä¸è‰¯å¿ƒç†ååº”çš„é£é™©ï¼Œå¦‚[ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)ã€[åæ‰§](/è¯æ•ˆ/åæ‰§.md)ã€[ææ…Œå‘ä½œ](/è¯æ•ˆ/ææ…Œå‘ä½œ.md)å’Œ[ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—…å‘ä½œ.md)ã€‚å»ºè®®ç”¨æˆ·ä»å¹³æ—¶å¤§éº»å‰‚é‡çš„ä¸€å°éƒ¨åˆ†å¼€å§‹ï¼Œå¹¶åœ¨æ¯ä¸€å£ä¹‹é—´é•¿æ—¶é—´ä¼‘æ¯ï¼Œä»¥é¿å…æ— æ„ä¸­è¿‡é‡ã€‚
*   **âš ï¸ [å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** - åƒ[è‹¯ä¸™èƒº](/è¯ç‰©/è‹¯ä¸™èƒº.md)ã€[å¯å¡å› ](/è¯ç‰©/å¯å¡å› .md)æˆ–[å“Œç”²é…¯](/è¯ç‰©/å“Œç”²é…¯.md)è¿™æ ·çš„å…´å¥‹å‰‚ä¼šå½±å“å¤§è„‘çš„è®¸å¤šéƒ¨åˆ†å¹¶æ”¹å˜[å¤šå·´èƒºèƒ½](/æ–‡æ¡£/å¤šå·´èƒº.md)åŠŸèƒ½ã€‚è¿™ç§ç»„åˆä¼šå¢åŠ [ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘.md)ã€[åæ‰§](/è¯æ•ˆ/åæ‰§.md)ã€[ææ…Œå‘ä½œ](/è¯æ•ˆ/ææ…Œå‘ä½œ.md)å’Œ[æ€ç»´å¾ªç¯](/è¯æ•ˆ/æ€ç»´å¾ªç¯.md)çš„é£é™©ã€‚è¿™ç§ç›¸äº’ä½œç”¨ä¹Ÿå¯èƒ½å¯¼è‡´[èºç‹‚](/è¯æ•ˆ/èºç‹‚.md)å’Œ[ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—…å‘ä½œ.md)çš„é£é™©å‡é«˜ã€‚
*   **âš ï¸ [æ›²é©¬å¤š](/è¯ç‰©/æ›²é©¬å¤š.md)** - æ›²é©¬å¤šè¢«å……åˆ†è¯æ˜ä¼šé™ä½ç™«ç—«é˜ˆå€¼ï¼Œè€Œ[è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)å¯èƒ½ä¼šåœ¨æ˜“æ„Ÿä¸ªä½“ä¸­å¼•å‘ç™«ç—«å‘ä½œã€‚

## æ³•å¾‹åœ°ä½

1P-LSDå¹¶æœªè¢«è”åˆå›½ç²¾ç¥è¯ç‰©å…¬çº¦åˆ—ç®¡å“¦ã€‚ä½†åœ¨è®¸å¤šå›½å®¶ï¼Œå®ƒè¢«è®¤ä¸ºå¤„äºæ³•å¾‹ç°è‰²åœ°å¸¦ï¼Œè¿™æ„å‘³ç€è™½ç„¶å®ƒæ²¡æœ‰è¢«æ˜ç¡®åˆ—ä¸ºéæ³•ï¼Œä½†åœ¨æŸäº›æƒ…å†µä¸‹ï¼ˆä¾‹å¦‚æ ¹æ®ç±»ä¼¼æ³•æ¡ˆï¼Œå¹¶ä¸”ä»¥é”€å”®æˆ–æ¶ˆè´¹ä¸ºç›®çš„ï¼‰ï¼Œä¸ªäººä»å¯èƒ½å› æŒæœ‰å®ƒè€Œå—åˆ°æŒ‡æ§ã€‚

*   **å¥¥åœ°åˆ©**: 1P-LSDåœ¨æŠ€æœ¯ä¸Šä¸è¿æ³•ï¼Œä½†å®ƒå¯èƒ½å±äºNPSGï¼ˆå¥¥åœ°åˆ©æ–°ç²¾ç¥æ´»æ€§ç‰©è´¨æ³•ï¼‰ï¼Œä½œä¸ºLSDçš„ç±»ä¼¼ç‰©ï¼Œä¾›åº”ç»™äººæ¶ˆè´¹æ˜¯è¿æ³•çš„å“¦ã€‚
*   **åŠ æ‹¿å¤§**: 1P-LSDæœªåœ¨ã€Šå—æ§è¯ç‰©å’Œç‰©è´¨æ³•ã€‹ä¸­æåŠï¼Œæ‰€ä»¥æŠ€æœ¯ä¸Šä¸è¿æ³•ã€‚
*   **æ·å…‹å…±å’Œå›½**: è‡ª2014å¹´1æœˆ1æ—¥èµ·ï¼Œ1P-LSDæ˜¯å—æ§ç‰©è´¨ã€‚
*   **ä¸¹éº¦**: æˆªè‡³2015å¹´8æœˆ25æ—¥ï¼Œ1P-LSDè¢«ç‰¹åˆ«åˆ—åœ¨éæ³•ç‰©è´¨åå•ä¸Šã€‚
*   **çˆ±æ²™å°¼äºš**: è‡ª2017å¹´6æœˆ1æ—¥èµ·ï¼Œ1P-LSDæ˜¯é™„è¡¨Iå—æ§ç‰©è´¨ã€‚
*   **èŠ¬å…°**: è‡ª2018å¹´11æœˆ15æ—¥èµ·ï¼Œ1P-LSDæ˜¯å—æ§ç‰©è´¨ã€‚
*   **å¾·å›½**: æˆªè‡³2019å¹´7æœˆ18æ—¥ï¼Œ1P-LSDå—NpSGï¼ˆæ–°ç²¾ç¥æ´»æ€§ç‰©è´¨æ³•ï¼‰ç®¡åˆ¶ã€‚ä»¥æŠ•æ”¾å¸‚åœºä¸ºç›®çš„çš„ç”Ÿäº§å’Œè¿›å£ã€å¯¹ä»–äººçš„ç®¡ç†å’Œäº¤æ˜“éƒ½æ˜¯å—æƒ©ç½šçš„ã€‚æŒæœ‰æ˜¯éæ³•çš„ï¼Œä½†ä¸ä¼šå—åˆ°æƒ©ç½šã€‚
*   **æ—¥æœ¬**: 1P-LSDæ˜¯å—æ§ç‰©è´¨ã€‚
*   **æ‹‰è„±ç»´äºš**: 1P-LSDåœ¨æ‹‰è„±ç»´äºšæ˜¯éæ³•çš„ã€‚è™½ç„¶å®ƒæ²¡æœ‰æ­£å¼åˆ—å…¥é™„è¡¨ï¼Œä½†æ ¹æ®2015å¹´6æœˆ1æ—¥çš„ä¿®æ­£æ¡ˆï¼Œå®ƒä½œä¸ºLSDç»“æ„ç±»ä¼¼ç‰©å—åˆ°ç®¡åˆ¶ã€‚
*   **ç«‹é™¶å®›**: 1P-LSDåœ¨ç«‹é™¶å®›æ˜¯éæ³•çš„ï¼Œè‡ª2015å¹´9æœˆ21æ—¥èµ·è¢«ç‰¹åˆ«åˆ—åœ¨éæ³•ç‰©è´¨åå•ä¸Šã€‚
*   **æŒªå¨**: è‡ª2013å¹´2æœˆ14æ—¥èµ·ï¼Œ1P-LSDæ˜¯å—æ§ç‰©è´¨ã€‚
*   **ç½—é©¬å°¼äºš**: 1P-LSDæ˜¯å—æ§ç‰©è´¨ã€‚
*   **æ–°åŠ å¡**: 1P-LSDæ˜¯Aç±»å—æ§ç‰©è´¨ã€‚
*   **ç‘å…¸**: ç»§ä½œä¸º[ç­–åˆ’è¯](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)é”€å”®åï¼Œ1P-LSDäº2016å¹´1æœˆ26æ—¥åœ¨ç‘å…¸è¢«åˆ—ä¸ºéæ³•ã€‚
*   **ç‘å£«**: 1P-LSDæ˜¯ç‰¹åˆ«åˆ—åœ¨Verzeichnis Eä¸‹çš„å—æ§ç‰©è´¨ã€‚æˆªè‡³2015å¹´12æœˆæ˜¯éæ³•çš„ã€‚
*   **åœŸè€³å…¶**: è‡ª2016å¹´2æœˆèµ·ï¼Œ1P-LSDåœ¨åœŸè€³å…¶æ˜¯éæ³•çš„ã€‚
*   **è‹±å›½**: æ ¹æ®2016å¹´5æœˆ26æ—¥ç”Ÿæ•ˆçš„ç²¾ç¥æ´»æ€§ç‰©è´¨æ³•ï¼Œç”Ÿäº§ã€ä¾›åº”æˆ–è¿›å£1P-LSDæ˜¯éæ³•çš„ã€‚
*   **ç¾å›½**: 1P-LSDåœ¨ç¾å›½æœªè¢«åˆ—å…¥é™„è¡¨ã€‚ç”±äº1P-LSDå¯ä»¥è¢«è®¤ä¸ºæ˜¯LSDçš„å‰è¯ï¼Œæ ¹æ®è”é‚¦ç±»ä¼¼ç‰©æ³•æ¡ˆï¼Œå…¶æŒæœ‰å’Œé”€å”®åœ¨ç¾å›½å¯èƒ½ä¼šå—åˆ°èµ·è¯‰ã€‚
*   **æ„å¤§åˆ©**: 1P-LSDæ˜¯é™„è¡¨Iè¯ç‰© (Tabella 1)ã€‚

## å¦è§

*   [è´Ÿè´£ä»»çš„ç”¨è¯](/æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)
*   [ç ”ç©¶ç”¨åŒ–å­¦å“](/æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)
*   [è¿·å¹»å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)
*   [éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/éº¦è§’é…¸é…°èƒºç±»ç‰©è´¨.md)
*   [LSD](/è¯ç‰©/LSD.md)
*   [ALD-52](/è¯ç‰©/ALD-52.md)
*   [AL-LAD](/è¯ç‰©/AL-LAD.md)

## å¤–éƒ¨é“¾æ¥

*   [1P-LSD (Wikipedia)](https://en.wikipedia.org/wiki/1P-LSD)
*   [1P-LSD (Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=5916)
*   [The Big & Dandy 1P-LSD Thread, Volume 1 (Bluelight)](http://www.bluelight.org/vb/threads/745848-The-Big-amp-Dandy-1P-LSD-Thread-Volume-1)

## æ–‡çŒ®

*   Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Hoang, K., ... & Halberstadt, A. L. (2016). Return of the lysergamides. Part I: Analytical and behavioural characterization of 1â€propionylâ€dâ€lysergic acid diethylamide (1Pâ€LSD). Drug Testing and Analysis, 8(9), 891-902. https://doi.org/10.1002/dta.1884
*   Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295â€“314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
*   Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., â€¦ Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113

## å‚è€ƒèµ„æ–™

1.  ["1P-LSD"](https://trends.google.com/trends/explore?date=all&q=1p-lsd). *Google Trends*. Retrieved January 1, 2020.
2.  Wagmann, Lea; Richter, Lilian H. J.; Kehl, Tobias; Wack, Franziska; Pettersson Bergstrand, Madeleine; Brandt, Simon D.; Stratford, Alexander; Maurer, Hans H.; Meyer, Markus R. (2019). "In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures". *Analytical and Bioanalytical Chemistry*. **411** (19): 4751â€“4763. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/s00216-018-1558-9](//doi.org/10.1007%2Fs00216-018-1558-9). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1618-2642](//www.worldcat.org/issn/1618-2642).
3.  Brandt, S. D.; Kavanagh, P. V.; Westphal, F.; Stratford, A.; Elliott, S. P.; Hoang, K.; Wallach, J.; Halberstadt, A. L. (2015). "Return of the lysergamides. Part I: Analytical and behavioural characterization of 1â€propionylâ€dâ€lysergic acid diethylamide (1P-LSD)". *Drug Testing and Analysis*. **8** (9): 891â€“902. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1002/dta.1884](//doi.org/10.1002%2Fdta.1884). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1942-7603](//www.worldcat.org/issn/1942-7603).
4.  Cooper, Donald A. (1988). ["Future Synthetic Drugs of Abuse"](https://www.erowid.org/library/books_online/future_synthetic/future_synthetic.shtml). *Proceedings of the international symposium on the forensic aspects of controlled substances*. p. 79. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [978-0-93211-509-6](http://en.wikipedia.org/wiki/Special:BookSources/978-0-93211-509-6).
5.  "Kman1898" (January 13, 2015). ["The Big & Dandy 1P-LSD Thread, Volume 1"](https://www.bluelight.org/xf/threads/the-big-dandy-1p-lsd-thread-volume-1.745848/page-2). Bluelight.org. Retrieved January 1, 2020.
6.  Grumann, C.; Henkel, K; Brandt, S. D.; Stratford, A.; Passie, T.; AuwÃ¤rter, V. (May 15, 2020). "Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration". *Drug Testing and Analysis*: 1â€“10. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1002/dta.2821](//doi.org/10.1002%2Fdta.2821). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1942-7611](//www.worldcat.org/issn/1942-7611). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1942-7603](//www.worldcat.org/issn/1942-7603). [OCLC](http://en.wikipedia.org/wiki/OCLC) [231680670](//www.worldcat.org/oclc/231680670). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [32415750](//www.ncbi.nlm.nih.gov/pubmed/32415750).
7.  Armstrong, B. D.; Paik, E.; Chhith, S.; Lelievre, V.; Waschek, J. A.; Howard, S. G. (2004). "Potentiation of (DL)â€3,4â€methylenedioxymethamphetamine (MDMA)â€induced toxicity by the serotonin 2A receptior partial agonist dâ€lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist MDL 11,939". *Neuroscience Research Communications*. **35** (2): 83â€“95. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1002/nrc.20023](//doi.org/10.1002%2Fnrc.20023). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1520-6769](//www.worldcat.org/issn/1520-6769).
8.  Gudelsky, Gary A.; Yamamoto, Bryan; Nash, J. Frank (1994). "Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists". *European Journal of Pharmacology*. **264** (3): 325â€“330. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/0014-2999(94)90669-6](//doi.org/10.1016%2F0014-2999%2894%2990669-6). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0014-2999](//www.worldcat.org/issn/0014-2999).
9.  Capela, J. P.; Fernandes, E.; RemiÃ£o, F.; Bastos, M. L.; Meisel, A.; Carvalho, F. (2007). "Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons". *Neurotoxicology*. **28** (4): 868â€“875. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.neuro.2007.04.005](//doi.org/10.1016%2Fj.neuro.2007.04.005). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0161-813X](//www.worldcat.org/issn/0161-813X). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [17572501](//www.ncbi.nlm.nih.gov/pubmed/17572501).
10. [Nichols, David E.](https://en.wikipedia.org/wiki/David_E._Nichols) (2004). "Hallucinogens". *Pharmacology & Therapeutics*. **101** (2): 131â€“181. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.pharmthera.2003.11.002](//doi.org/10.1016%2Fj.pharmthera.2003.11.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0163-7258](//www.worldcat.org/issn/0163-7258).
11. Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009). "Dose-independent occurrence of seizure with tramadol". *Journal of Medical Toxicology*. **5** (2): 63â€“67. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/BF03161089](//doi.org/10.1007%2FBF03161089). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1556-9039](//www.worldcat.org/issn/1556-9039).
12. ["Synthetische Drogen: Neues Gesetz soll "Legal Highs" bekÃ¤mpfen"](https://www.derstandard.at/story/1317018702282/kraeutermischungen-synthetische-drogen-neues-gesetz-soll-legal-highs-bekaempfen) [Synthetic drugs: New law is to combat legal highs] (in German). Der Standard. September 28, 2011. Retrieved January 1, 2020.
13. ["Entwurf: Bundesgesetz, mit dem ein Bundesgesetz Ã¼ber den Schutz vor Gesundheitsgefahren im Zusammenhang mit Neuen Psychoaktiven Substanzen (Neue-Psychoaktive-Substanzen-Gesetz, NPSG) erlassen und das Suchtmittelgesetz (SMG) geÃ¤ndert wird"](https://www.parlament.gv.at/PAKT/VHG/XXIV/ME/ME_00317/imfname_231611.pdf) (PDF) (in German). Retrieved January 1, 2020.
14. ["NaÅ™Ã­zenÃ­ vlÃ¡dy Ä. 463/2013 Sb. NaÅ™Ã­zenÃ­ vlÃ¡dy o seznamech nÃ¡vykovÃ½ch lÃ¡tek"](https://www.zakonyprolidi.cz/cs/2013-463) (in Czech). ZÃ¡kony pro lidi. December 18, 2013. 178/2013.
15. ["BekendtgÃ¸relse om euforiserende stoffer - ni nye stoffer tilfÃ¸jet"](https://laegemiddelstyrelsen.dk/da/nyheder/2015/bekendtgoerelse-om-euforiserende-stoffer-ni-nye-stoffer-tilfoejet) (in Danish). Danish Medicines Ageny. August 31, 2015. Retrieved January 1, 2020.
16. ["Muudatus narkootiliste ja psÃ¼hhotroopsete ainete I nimekirjas"](https://www.sam.ee/en/node/10831) (in Estonian). State Agency of Medicines. June 13, 2017.
17. ["Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistÃ¤ psykoaktiivisista aineista annetun valtioneuvoston asetuksen liitteen muuttamisesta"](https://www.finlex.fi/fi/laki/alkup/2018/20180840) [Government decree amending the annex to the government decree on psychoactive substances prohibited on the consumer market] (in Finnish). Finlex. October 25, 2018. 840/2018.
18. ["Anlage NpSG"](https://www.gesetze-im-internet.de/npsg/anlage.html) (in German). Bundesministerium der Justiz und fÃ¼r Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]. Retrieved December 10, 2019.
19. ["Verordnung zur Ã„nderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des BetÃ¤ubungsmittelgesetzes"](http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl119s1083.pdf) (PDF). *Bundesgesetzblatt Jahrgang 2019 Teil I Nr. 27* (in German). Bundesanzeiger Verlag. July 17, 2019. pp. 1083â€“1094. Retrieved January 1, 2020.
20. ["Â§ 4 NpSG"](https://www.gesetze-im-internet.de/npsg/__4.html) (in German). Bundesministerium der Justiz und fÃ¼r Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]. Retrieved December 10, 2019.
21. ["æŒ‡å®šè–¬ç‰©ä¸€è¦§"](http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/dl/meisho.pdf) (PDF) (in Japanese). åšç”ŸåŠ´åƒçœ [Ministry of Health, Labour and Welfare].
22. ["Noteikumi par LatvijÄ kontrolÄ“jamajÄm narkotiskajÄm vielÄm, psihotropajÄm vielÄm un prekursoriem"](http://likumi.lv/doc.php?id=121086) (in Latvian). VSIA Latvijas VÄ“stnesis. November 10, 2005. Retrieved January 1, 2020.
23. ["LR SAM Ä®sakymas DÄ—l NarkotiniÅ³ ir psichotropiniÅ³ medÅ¾iagÅ³ sÄ…raÅ¡Å³ patvirtinimo"](https://www.e-tar.lt/portal/lt/legalActEditions/TAR.7B3B40DCD13A) (in Lithuanian). Retrieved January 1, 2020.
24. ["31 Forskrift om narkotika (narkotikaforskriften)"](https://lovdata.no/dokument/SF/forskrift/2013-02-14-199) (in Norwegian). Lovdata.
25. ["Legea 194/2011 privind combaterea operatiunilor cu produse susceptibile de a avea efecte psihoactive, altele decat cele prevazute de acte normative in vigoare, republicata 2014"](http://www.dreptonline.ro/legislatie/legea_194_2011_combaterea_operatiunilor_produse_susceptibile_efecte_psihoactive.php). *Monitorul Oficial, Partea I*. February 26, 2014.
26. ["Misuse of Drugs Act: (CHAPTER 185)"](https://sso.agc.gov.sg/Act/MDA1973). *sso.agc.gov.sg*. March 31, 2008. Retrieved October 22, 2020.
27. ["31 nya substanser klassas som narkotika eller hÃ¤lsofarlig vara"](https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2016/januari/31-nya-substanser-klassas-som-narkotika-eller-halsofarlig-vara) (in Swedish). FolkhÃ¤lsomyndigheten [Public Health Agency of Sweden]. January 26, 2016. Retrieved January 1, 2020.
28. ["Verordnung des EDI Ã¼ber die Verzeichnisse der BetÃ¤ubungsmittel, psychotropen Stoffe, VorlÃ¤uferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
29. ["Karar SayÄ±sÄ± : 2016/8548"](https://www.resmigazete.gov.tr/eskiler/2016/03/20160308-4.pdf) (PDF) (in Turkish). Resmi Gazete. Retrieved January 15, 2020.
30. ["Psychoactive Substances Act 2016"](http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted). UK Government. Retrieved January 1, 2020.
31. ["Introduction to the Federal Controlled Substance Analogue Act"](https://erowid.org/psychoactives/law/analog/analog_info1.shtml). Erowid. January 2001. Retrieved January 1, 2020.
32. MINISTERO DELLA SALUTE, DECRETO 5 ottobre 2021 https://www.gazzettaufficiale.it/atto/vediMenuHTML?atto.dataPubblicazioneGazzetta=2021-10-18&atto.codiceRedazionale=21A06118&tipoSerie=serie_generale&tipoVigenza=originario